PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1974 July; 67(7): 667–669.
PMCID: PMC1651739

Gonadal hormones and triglycerides.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (547K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Corredor DG, Mendelsohn LV, Sabeh G, Sunder JH, Danowski TS. Serum lipids during oral contraceptive exposure. Clin Pharmacol Ther. 1970 Mar-Apr;11(2):188–193. [PubMed]
  • Gershberg H, Hulse M, Javier Z. Hypertriglyceridemia during treatment with estrogen and oral contraceptives. An alteration in hepatic function? Obstet Gynecol. 1968 Feb;31(2):186–189. [PubMed]
  • Glueck CJ, Ford S, Jr, Steiner P, Buxton S, Fallat R. Effects of a progestational oral contraceptive on lipids and lipases. Am J Obstet Gynecol. 1973 Jul 1;116(5):689–693. [PubMed]
  • Glueck CJ, Ford S, Jr, Steiner P, Fallat R. Triglyceride removal efficiency and lipoprotein lipases: effects of Oxandrolone. Metabolism. 1973 Jun;22(6):807–814. [PubMed]
  • Glueck CJ, Levy RI, Fredrickson DS. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons. Ann Intern Med. 1971 Sep;75(3):345–352. [PubMed]
  • Glueck CJ, Scheel D, Fishback J, Steiner P. Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism. 1972 Jul;21(7):657–666. [PubMed]
  • Glueck CJ. Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia. Metabolism. 1971 Jul;20(7):691–702. [PubMed]
  • Hazzard WR, Spiger MJ, Bagdade JD, Bierman EL. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med. 1969 Feb 27;280(9):471–474. [PubMed]
  • Kekki M, Nikkilä EA. Plasma triglyceride turnover during use of oral contraceptives. Metabolism. 1971 Sep;20(9):878–889. [PubMed]
  • LaRosa JC, Levy RI, Windmueller HG, Fredrickson DS. Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J Lipid Res. 1972 May;13(3):356–363. [PubMed]
  • Reaven GM, Hill DB, Gross RC, Farquhar JW. Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. J Clin Invest. 1965 Nov;44(11):1826–1833. [PMC free article] [PubMed]
  • Rössner S, Larsson-Cohn U, Carlson LA, Boberg J. Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. Acta Med Scand. 1971 Oct;190(4):301–305. [PubMed]
  • Sachs BA, Wolfman L, Herzig N. Plasma lipid and lipoprotein alterations during oral contraceptive administration. Obstet Gynecol. 1969 Oct;34(4):530–535. [PubMed]
  • Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. [PubMed]
  • Sodhi HS, Kudchodkar BJ, Horlick L. Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man. Metabolism. 1971 Mar;20(3):309–318. [PubMed]
  • Stokes T, Wynn V. Serum-lipids in women on oral contraceptives. Lancet. 1971 Sep 25;2(7726):677–680. [PubMed]
  • Ben-Ezzer J, Rimington C, Shani M, Seligsohn U, Sheba C, Szeinberg A. Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. Clin Sci. 1971 Jan;40(1):17–30. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press